DeSantisCE, LinCC, MariottoAB, et al.: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin, 2014; 64:252–271.
2.
GoreJL, GollapudiK, BergmanJ, et al.: Correlates of bother following treatment for clinically localized prostate cancer. J Urol, 2010; 184:1309–1315.
3.
ParryC, LomaxJB, MorningstarEA, FaircloughDL: Identification and correlates of unmet service needs in adult leukemia and lymphoma survivors after treatment. J Oncol Pract, 2012; 8:e135–e141.
4.
BartulaI, ShermanKA: Screening for sexual dysfunction in women diagnosed with breast cancer: Systematic review and recommendations. Breast Cancer Res Treat, 2013; 141:173–185.
5.
HordernAJ, StreetAF: Communicating about patient sexuality and intimacy after cancer: Mismatched expectations and unmet needs. Med J Aust, 2007; 186:224–227.
6.
ParkER, BoberSL, CampbellEG, et al.: General internist communication about sexual function with cancer survivors. J Gen Intern Med, 2009; 24:S407–S411.
7.
FlynnKE, ReeseJB, JefferyDD, et al.: Patient experiences with communication about sex during and after treatment for cancer. Psycho-oncology, 2012; 21:594–601.
8.
BrottoLA, YuleM, BreckonE: Psychological interventions for the sexual sequelae of cancer: A review of the literature. J Cancer Surviv, 2010; 4:346–360.
9.
AlthofSE, ParishSJ: Clinical interviewing techniques and sexuality questionnaires for male and female cancer patients. J Sex Med, 2013; 10:S35–S42.
10.
MilesT, JohnsonN: Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev, 2010:CD007291.
11.
BigliaN, PeanoE, SgandurraP, et al.: Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: A preliminary study. Gynecol Endocrinol, 2010; 26:404–412.
12.
DewJE, WrenBG, EdenJA: A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric, 2003; 6:45–52.
13.
Al-BaghdadiO, EwiesAA: Topical estrogen therapy in the management of postmenopausal vaginal atrophy: An up-to-date overview. Climacteric, 2009; 12:91–105.
14.
CuiY, ZongH, YanH, ZhangY: The effect of testosterone replacement therapy on prostate cancer: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis, 2014; 17:132–143.
15.
ShererBA, LevineLA: Current management of erectile dysfunction in prostate cancer survivors. Curr Opin Urol, 2014; 24:401–406.
16.
Padma-NathanH, McCulloughAR, LevineLA, et al.: Randomized, double-blind, placebo controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res, 2008; 20:479–486.
17.
RamsawhHJ, MorgentalerA, CovinoN, et al.: Quality of life following simultaneous placement of penile prosthesis with radical prostatectomy. J Urol, 2005; 174:1395–1398.
18.
BrisonD, SeftelA, Sadeghi-NejadH: The resurgence of the vacuum erection device (VED) for treatment of erectile dysfunction. J Sex Med, 2013; 10:1124–1135.
19.
MontorsiF, GuazzoniG, StrambiLF, et al.: Recovery of spontaneous erectile function after nerve sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. J Urol, 1997; 158:1408–1410.
20.
ScottJL, KayserK: A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J, 2009; 15:48–56.
21.
ReeseJB, KeefeFJ, SomersTJ, AbernethyAP: Coping with sexual concerns after cancer: The use of flexible coping. Support Care Cancer, 2010; 18:785–800.
